Pancreatic Cancer Research

ResearcherPeking UniversityActive in the last 2 years

Jikui Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2625-3810; OpenAlex author ID A5067785690. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 5

  1. Effect of Bioactive Black Phosphorus Nanomaterials on Cancer-Associated Fibroblast Heterogeneity in Pancreatic Cancer. Co-author DOI 10.1021/acsnano.4c06147↗
  2. System Analysis Based on Pancreatic Cancer Progression Identifies BRINP2 as a Novel Prognostic Biomarker. Last author DOI 10.1615/critreveukaryotgeneexpr.2023048337↗
  3. Identifying a baicalein-related prognostic signature contributes to prognosis prediction and tumor microenvironment of pancreatic cancer. Co-author DOI 10.3389/fimmu.2023.1223650↗
  4. NEK7 Promotes Pancreatic Cancer Progression And Its Expression Is Correlated With Poor Prognosis. Last author DOI 10.3389/fonc.2021.705797↗
  5. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathwa… Co-author DOI 10.1007/s12253-018-0487-4↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zilong Yan · 3 shared papers, 2021–2024 · strength 0.50
  2. Zhengquan Lai · 2 shared papers, 2023–2024 · strength 0.37
  3. Biao Zheng · 2 shared papers, 2023–2024 · strength 0.37
  4. Jianhua Qu · 2 shared papers, 2021–2024 · strength 0.33
  5. Yixing Kang · 1 shared paper, 2023 · strength 0.31
  6. Shengyong Geng · 1 shared paper, 2024 · strength 0.20
  7. Citing Zhang · 1 shared paper, 2023 · strength 0.17
  8. Xi Ou · 1 shared paper, 2019 · strength 0.11
  9. Xiaoping Liu · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.